About: COVID-19 experience: first Italian survey on healthcare staff members from a Mother-Child Research hospital using combined molecular and rapid immunoassays test

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19 experience: first Italian survey on healthcare staff members from a Mother-Child Research hospital using combined molecular and rapid immunoassays test Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	COVID-19 experience: first Italian survey on healthcare staff members from a Mother-Child Research hospital using combined molecular and rapid immunoassays test
Creator	Argentini, Bianca, Martina Bianco, Annamonica Bicego, Livia Bottega, Roberta Brumat, Marco Carli, Petra Cassone, Andrea Catamo, Eulalia Cocca, Massimiliano Comar, Manola Concas, Feresin, Agnese Gasparini, Paolo Girotto, Giorgia Morassut, Sara Morgan, Anna Pelliccione, Giulia Petix, Vincenzo Pin, Massimo Ragusa, Giulia Robino, Antonietta Russian, Stefano Spedicati, Beatrice Stazio, Mariateresa Suergiu, Sarah Toscani, Paola Urriza, Marianela Vascotto, Fulvia
source	MedRxiv
abstract	The fast spread of the novel coronavirus (SARS-CoV-2) has become a global threat hitting the worldwide fragile health care system. In Italy, there is a continued COVID-19 growth of cases and deaths that requires control measures for the correct management of the epidemiological emergency. To contribute to increasing the overall knowledge of COVID-19, systematic tests in the general population are required. Here, we describe the first Italian survey performed in 727 employees belonging to a Mother-Child Research hospital tested for both viral (nasopharyngeal and oropharyngeal swabs) and antibody presence. Individuals were divided into three risk categories (high, medium and low) according to their job activity. Only one subject was positive at the swab test while 17.2% of the cohort was positive for the presence of antibodies. Results highlighted that the presence of Positive antibodies is significantly associated with high and medium risk exposure occupation (p-value=0.026) as well as cold and conjunctivitis symptoms (p-value=0.016 and 0.042 respectively). Moreover, among healthcare professionals, the category of medical doctors showed a significant association with the presence of antibodies against SARS-CoV-2 (p-value=0.0127). Finally, we detected a rapid decrease in antibody intensity between two assessments performed within a very short period (p-value=0.009). Overall, the present study increases our knowledge of the epidemiological data of COVID-19 infection in Italy, suggesting a high prevalence of immune individuals (i.e. at least among at-risk categories) and the efficacy of the combined diagnostic protocol to monitor the possible outbreak.
has issue date	2020-04-22(xsd:dateTime)
bibo:doi	10.1101/2020.04.19.20071563
has license	medrxiv
sha1sum (hex)	9c73205f1f2ad5ae5df300ffd6d075a93221c531
schema:url	https://doi.org/10.1101/2020.04.19.20071563
resource representing a document's title	COVID-19 experience: first Italian survey on healthcare staff members from a Mother-Child Research hospital using combined molecular and rapid immunoassays test
resource representing a document's body	covid:9c73205f1f2ad5ae5df300ffd6d075a93221c531#body_text
is schema:about of	named entity 'measures' named entity 'NOVEL CORONAVIRUS' named entity 'EPIDEMIOLOGICAL' named entity 'TESTS' named entity 'The' named entity 'systematic' named entity 'coronavirus' named entity 'Italy' named entity 'general population' named entity 'Chi-squared test' named entity 'Europe' named entity 'Italian' named entity 'infection' named entity 'COVID' named entity 'SARS-CoV-2 virus' named entity 'p-value' named entity 'medRxiv' named entity 'laboratory confirmation of COVID-19' named entity 'symptom' named entity 'symptom' named entity 'bronchoalveolar lavage' named entity 'P/B' named entity 'SARS-CoV' named entity 'MERS-CoV' named entity 'antibody test' named entity 'Iceland' named entity 'Chi-squared test' named entity 'SARS-CoV-2' named entity 'Italy' named entity 'peer review' named entity 'COVID-19' named entity 'antibody test' named entity 'infection' named entity 'COVID-19 pandemic in Italy' named entity 'genome' named entity 'pangolins' named entity 'Italy' named entity 'serological' named entity 'Chi-squared test' named entity 'COVID' named entity 'real number' named entity 'animal reservoir' named entity 'COVID-19' named entity 'peer review' named entity 'Logistic regression' named entity 'oropharyngeal' named entity 'Multivariate analysis' named entity 'P/B' named entity 'World Health Organization' named entity 'coronavirus' named entity 'reinfected' named entity 'preprint' named entity 'public health' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'antibodies' named entity 'Coronavirus'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software